The DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.
Efficacy of 5-Aminosalicylates in Ulcerative Colitis: Systematic Review and Meta-Analysis
Abstract
OBJECTIVES: The efficacy of 5-aminosalicylic acids (5-ASAs) in ulcerative colitis (UC) has been studied previously in meta-analyses. However, several randomized controlled trials (RCTs) have been published recently, and no previous meta-analysis has studied the effect of 5-ASA dosage used. METHODS: MEDLINE, EMBASE, and the Cochrane central register of controlled trials were searched (through December 2010). Eligible trials recruited adults with active or quiescent UC, comparing different doses of 5-ASAs with themselves or placebo. Dichotomous data were pooled to obtain relative risk (RR) of failure to achieve remission in active UC, and RR of relapse of disease activity in quiescent UC, with a 95% confidence interval (CI). The number needed to treat (NNT) was calculated from the reciprocal of the risk difference. RESULTS: The search identified 3,061 citations, and 37 RCTs were eligible. Of these, 11 compared 5-ASA with placebo in active UC remission, with the RR of no remission with 5-ASAs of 0.79 (95% CI 0.73-0.85; NNT=6). Doses of ≥ 2.0 g/day were more effective than <2.0 g/day for remission (RR=0.91; 95% CI 0.85-0.98). There were 11 RCTs comparing 5-ASAs with placebo in preventing relapse of quiescent UC, with the RR of relapse of 0.65 (95% CI 0.55-0.76; NNT=4). Doses of ≥ 2.0 g/day appeared more effective than <2.0 g/day for preventing relapse (RR=0.79; 95% CI 0.64-0.97). CONCLUSIONS: 5-ASAs are highly effective for inducing remission and preventing relapse in UC. Evidence suggests that doses of ≥ 2.0 g/day have greater efficacy, although doses >2.5 g/day do not appear to lead to higher remission rates.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Measuring inconsistency in meta-analyses
Higgins, J. P. T., Thompson, S. G., Deeks, J. J., & Altman, D. G. (2003) · BMJ · doi:10.1136/bmj.327.7414.557 · Cited by 63,139
Bias in meta-analysis detected by a simple, graphical test
Egger, M., Smith, G. D., Schneider, M., & Minder, C. (1997) · BMJ · doi:10.1136/bmj.315.7109.629 · Cited by 56,722
Meta-analysis in clinical trials
DerSimonian, R., & Laird, N. (1986) · Controlled Clinical Trials · doi:10.1016/0197-2456(86)90046-2 · Cited by 39,552
Coated Oral 5-Aminosalicylic Acid Therapy for Mildly to Moderately Active Ulcerative Colitis
Schroeder, K. W., Tremaine, W. J., & Ilstrup, D. M. (1987) · New England Journal of Medicine · doi:10.1056/nejm198712243172603 · Cited by 3,026
Cortisone in Ulcerative Colitis
Truelove, S. C., & Witts, L. J. (1955) · BMJ · doi:10.1136/bmj.2.4947.1041 · Cited by 2,767
Kappelman, M. D., Rifas–Shiman, S. L., Kleinman, K., Ollendorf, D., Bousvaros, A., Grand, R. J., & Finkelstein, J. A. (2007) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2007.07.012 · Cited by 932
Loftus, C. G., Loftus, E. V., Harmsen, S. W., Zinsmeister, A. R., Tremaine, W. J., Melton, J. L., & Sandborn, W. J. (2007) · Inflammatory Bowel Diseases · doi:10.1002/ibd.20029 · Cited by 644
Rousseaux, C., Lefebvre, B., Dubuquoy, L., Lefebvre, P., Romano, O., Auwerx, J., Metzger, D., Wahli, W., Desvergne, B., Naccari, G. C., et al. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20041948 · Cited by 526
Oral 5-aminosalicylic acid for induction of remission in ulcerative colitis
Wang, Y., Parker, C. E., Bhanji, T., Feagan, B. G., & MacDonald, J. K. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000543.pub4 · Cited by 494
Ulcerative colitis in Olmsted County, Minnesota, 1940–1993: incidence, prevalence, and survival
Loftus, E. V., Silverstein, M. D., Sandborn, W. J., Tremaine, W. J., Harmsen, W. S., & Zinsmeister, A. R. (2000) · Gut · doi:10.1136/gut.46.3.336 · Cited by 492
CONTROLLED TRIAL OF SULPHASALAZINE IN MAINTENANCE THERAPY FOR ULCERATIVE COLITIS
Misiewicz, J. J., Lennard-Jones, J. E., Connell, A. M., Baron, J. H., & Avery Jones, F. (1965) · The Lancet · doi:10.1016/s0140-6736(65)90972-4 · Cited by 360
Once-Daily, High-Concentration MMX Mesalamine in Active Ulcerative Colitis
Kamm, M. A., Sandborn, W. J., Gassull, M., Schreiber, S., Jackowski, L., Butler, T., Lyne, A., Stephenson, D., Palmen, M., & Joseph, R. E. (2007) · Gastroenterology · doi:10.1053/j.gastro.2006.10.011 · Cited by 352
Dissanayake, A. S., & Truelove, S. C. (1973) · Gut · doi:10.1136/gut.14.12.923 · Cited by 339
Azathioprine in Ulcerative Colitis: Final Report on Controlled Therapeutic Trial
Jewell, D. P., & Truelove, S. C. (1974) · BMJ · doi:10.1136/bmj.4.5945.627 · Cited by 332
Hanauer, S. B., Sandborn, W. J., Kornbluth, A., Katz, S., Safdi, M., Woogen, S., Regalli, G., Yeh, C., Smith-Hall, N., & Ajayi, F. (2005) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2005.00248.x · Cited by 322
SULPHASALAZINE AND SALICYLAZOSULPHADIMIDINE IN ULCERATIVE COLITIS
Baron, J. H., Connell, A. M., Lennard-Jones, J. E., & Avery Jones, F. (1962) · The Lancet · doi:10.1016/s0140-6736(62)92080-9 · Cited by 287
Lichtenstein, G. R., Kamm, M. A., Boddu, P., Gubergrits, N., Lyne, A., Butler, T., Lees, K., Joseph, R. E., & Sandborn, W. J. (2007) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2006.10.025 · Cited by 267
Hanauer, S., SCHWARTZ, J., ROBINSON, M. G., Roufail, W. M., Arora, S., Cello, J. P., & Safdi, M. A. (1993) · PubMed · Cited by 266
Controlled trial of sulphasalazine in the treatment of ulcerative colitis
Dick, A. P., Grayson, M. J., Carpenter, R. G., & Petrie, A. (1964) · Gut · doi:10.1136/gut.5.5.437 · Cited by 243
Sutherland, L. R., May, G. R., & Shaffer, E. A. (1993) · Annals of Internal Medicine · doi:10.7326/0003-4819-118-7-199304010-00009 · Cited by 230
Lennard-Jones, J. E., Longmore, A. J., Newell, A. C., Wilson, C. W. E., & Jones, F. A. (1960) · Gut · doi:10.1136/gut.1.3.217 · Cited by 227
Optimum dose of sulphasalazine for maintenance treatment in ulcerative colitis.
Azad Khan, A. K., Howes, D. T., Piris, J., & Truelove, S. C. (1980) · Gut · doi:10.1136/gut.21.3.232 · Cited by 215
Riley, S. A., Mani, V, Goodman, M. J., Herd, M. E., Dutt, S., & Turnberg, L. A. (1988) · Gut · doi:10.1136/gut.29.5.669 · Cited by 193
Azodisal sodium in the treatment of ulcerative colitis
Sandberg-Gertzén, H., Järnerot, G., & Kraaz, W. (1986) · Gastroenterology · doi:10.1016/0016-5085(86)90882-6 · Cited by 187
Oral 5-aminosalicylic acid for induction of remission in ulcerative colitis
Sutherland, L. R., & MacDonald, J. K. (2006) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000543.pub2 · Cited by 184
Sandborn, W. J., Regula, J., Feagan, B. G., Belousova, E., Jojic, N., Lukas, M., Yacyshyn, B., Krzeski, P., Yeh, C., Messer, C. A., et al. (2009) · Gastroenterology · doi:10.1053/j.gastro.2009.08.069 · Cited by 169
Hanauer, S. B., Sandborn, W. J., Dallaire, C., Archambault, A., Yacyshyn, B., Yeh, C., & Smith-Hall, N. (2007) · Canadian Journal of Gastroenterology · doi:10.1155/2007/862917 · Cited by 164
An Oral Preparation of Mesalamine as Long-Term Maintenance Therapy for Ulcerative Colitis
Hanauer, S. B., Sninsky, C. A., Robinson, M., Powers, B. J., McHattie, J. D., Mayle, J. E., Elson, C. O., DeMicco, M. P., Butt, J. H., Pruitt, R. E., et al. (1996) · Annals of Internal Medicine · doi:10.7326/0003-4819-124-2-199601150-00003 · Cited by 155
Levine, D. S., Riff, D. S., Pruitt, R. E., Wruble, L. D., Koval, G., Sales, D. J., Bell, J. K., & Johnson, L. K. (2002) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2002.05781.x · Cited by 149
Pentasa UC Maintenance Study Group, Miner, P. B., Hanauer, S. B., ROBINSON, M. G., Schwartz, J., & Arora, S. (1995) · Digestive Diseases and Sciences · doi:10.1007/bf02065413 · Cited by 135
Hawkey, C., Dubé, L. M., Rountree, L., Linnen, P., & Lancaster, J. F. (1997) · Gastroenterology · doi:10.1053/gast.1997.v112.pm9041232 · Cited by 114
Kruis, W., Schreiber, S., Theuer, D., Brandes, J.-W., Schütz, E., Howaldt, S., Krakamp, B., Hämling, J., Mönnikes, H., Koop, I., et al. (2001) · Gut · doi:10.1136/gut.49.6.783 · Cited by 112
The beneficial effect of azathioprine on maintenance of remission in severe ulcerative colitis
Sood, A., Kaushal, V., Midha, V., Bhatia, K. L., Sood, N., & Malhotra, V. (2002) · Journal of Gastroenterology · doi:10.1007/s005350200034 · Cited by 109
Fockens, P., Mulder, C. J. J., Tytgat, G. N. J., Blok, P., & Ferwerda, J. (1995) · European Journal of Gastroenterology & Hepatology · doi:10.1097/00042737-199511000-00003 · Cited by 103
Is maintenance therapy always necessary for patients with ulcerative colitis in remission?
Ardizzone, S., Petrillo, Имбеси, CERUTTI, BOLLANI, & Porro, B. (1999) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.1999.00473.x · Cited by 84
Paoluzi, O. A., Iacopini, F., Pica, R., Crispino, P., Marcheggiano, A., Consolazio, A., Rivera, M., & Paoluzi, P. (2005) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2005.02458.x · Cited by 84
Kruis, W., Jonaitis, L. V., Pokrotnieks, J., Mikhailova, T. L., Horynski, M., Bátovský, M., Lozynskyy, Y., Zakharash, Y. M., Rácz, I. A., Kull, K., et al. (2010) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2010.04537.x · Cited by 79
Ito, H., Iida, M., Matsumoto, T., Suzuki, Y., Sasaki, H., Yoshida, T., Takano, Y., & Hibi∥, T. (2010) · Inflammatory Bowel Diseases · doi:10.1002/ibd.21193 · Cited by 76
Optimum dose of olsalazine for maintaining remission in ulcerative colitis.
Travis, S. P. L., Tysk, C., de Silva, H. J., Sandberg–Gertzén, H., Jewell, D. P., & Järnerot, G. (1994) · Gut · doi:10.1136/gut.35.9.1282 · Cited by 74
Riis, P. M., ANTHONISEN, P., Hr, W., Folkenborg, O., Bonnevie, O., & Binder, M. J. (1973) · PubMed · Cited by 74
Olsalazine in maintenance of clinical remission in patients with ulcerative colitis
Wright, J. P., O'Keefe, E. A., Cuming, L., & Jaśkiewicz, K. (1993) · Digestive Diseases and Sciences · doi:10.1007/bf01296107 · Cited by 69
The Prophylactic Effect of Salazosulphapyridine in Ulcerative Colitis during Long-Term Treatment
Riis, P., ANTHONISEN, P., Wulff, H. R., Folkenborg, O., Bonnevie, O., & Binder, V. (1973) · Scandinavian Journal of Gastroenterology · doi:10.1080/00365521.1973.12096672 · Cited by 61
Ford, A. C., Guyatt, G. H., Talley, N. J., & Moayyedi, P. (2009) · The American Journal of Gastroenterology · doi:10.1038/ajg.2009.658 · Cited by 55
Self-citationLichtenstein, G. R., Gordon, G. L., Zakko, S. F., et al. (2010) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2010.04438.x · Cited by 53
Lauritsen, K., Laursen, L., Bukhave, K., et al. (1988) · Gut · doi:10.1136/gut.29.10.1316 · Cited by 45
Cited by
Ungaro, R., Mehandru, S., Allen, P. B., Peyrin-Biroulet, L., & Colombel, J.-F. (2017) · The Lancet · doi:10.1016/s0140-6736(16)32126-2 · Cited by 3,531
Lamb, C. A., Kennedy, N. A., Raine, T., Hendy, P. A., Smith, P. J., Limdi, J. K., Hayee, B., Lomer, M. C. E., Parkes, G. C., Selinger, C., et al. (2019) · Gut · doi:10.1136/gutjnl-2019-318484 · Cited by 2,346
ACG Clinical Guideline: Ulcerative Colitis in Adults
Rubin, D. T., Ananthakrishnan, A. N., Siegel, C. A., Sauer, B. G., & Long, M. D. (2019) · American Journal of Gastroenterology · doi:10.14309/ajg.0000000000000152 · Cited by 1,577
Dignass, A., Lindsay, J. O., Sturm, A., Windsor, A., Colombel, J.-F., Allez, M., D'Haens, G., D'Hoore, A., Mantzaris, G., Novacek, G., et al. (2012) · Journal of Crohn's and Colitis · doi:10.1016/j.crohns.2012.09.002 · Cited by 1,548
Moayyedi, P., Surette, M. G., Kim, P. T., Libertucci, J., Wolfe, M., Onischi, C., Armstrong, D., Marshall, J. K., Kassam, Z., Reinisch, W., et al. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.04.001 · Cited by 1,499
Self-citation
Metadata
- Authors
- Ford, A. C., Achkar, J.-P., Khan, K. J., Kane, S. V., Talley, N. J., Marshall, J. K., & Moayyedi, P.
- Venue
- American Journal of Gastroenterology
- Published
- 2011-04
- Volume
- 106
- Issue
- 4
- Pages
- 601-616
- ISSN
- 0002-9270 (ISSN-L)
- OpenAlex
- W2138119117
- Cited by
- 295
- References
- 45
- FWCI
- 1.66
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.